trending Market Intelligence /marketintelligence/en/news-insights/trending/gAOMbe5Sj_MWTQ8gQtGE6g2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

Great-West Lifeco receives TSX approval for normal course issuer bid

Part Two IFRS 9 Blog Series: The Need to Upgrade Analytical Tools

2018 US Property Casualty Insurance Market Report

Fintech

Fintech Funding Flows To Insurtech In February

Lemonade Growing Premiums Faster Than Esurance's Homeowners Business Did


Great-West Lifeco receives TSX approval for normal course issuer bid

Great-West Lifeco Inc. received approval from the Toronto Stock Exchange for the renewal of its normal course issuer bid to purchase for cancellation up to 20 million of its common shares, equivalent to approximately 2.16% of its issued and outstanding common shares.

The normal course issuer bid will commence Jan. 22, 2020, and will expire Jan. 21, 2021. The company intends to use the normal course issuer bid to mitigate the dilutive effect of issuing securities under its stock option plan and for other capital management purposes.

Under its previous normal course issuer bid, which was terminated Jan. 17, the company purchased 2 million of its common shares at a weighted average price of C$32.90 per share for the period of Feb. 1, 2019, to Jan. 31, 2020. A non-independent trustee purchased an additional 368,883 common shares at a weighted average price of C$31.08 per share.

The 2,368,883 common shares purchased under the previous normal course issuer bid will be deducted from the 20 million common share limit of the renewed normal course issuer bid.